NAS:IBB
iShares Biotechnology ETF | |
| $ 187.36 3.69 ( +2.01%) 04:00 PM EST | |
PE Ratio:
22.58
PB Ratio:
4.78
Volume:
2.09M
Dividend Yield %:
0.22
| |
| Last Holding update 2026-05-31 | 246 Stocks (1 new) |
| Value $8.11 Bil | Turnover 4 % |
Registrant: iShares Biotechnology ETF
| |
Year: 2026
GuruFocus Rankings
Financial Strength
7 /10
Profitability Rank
5 /10
GF Value Rank
6 /10
Growth Rank
8 /10
Momentum Rank
5 /10
iShares Biotechnology ETF Geographic Breakdown
iShares Biotechnology ETF Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
iShares Biotechnology ETF Key Statistics
| Name | Value | ||
|---|---|---|---|
| Day's Open ($) | 183.82 | ||
| Day's Range ($) | 183.51 - 188.69 | ||
| Day's Volume | 2,086,827 | ||
| 52-Week Range ($) | 125.7 - 188.69 | ||
| Beta | 0.6942 | ||
| 3-Year Sharpe Ratio | 0.44 | ||
| 3-Year Sortino Ratio | 0.73 | ||
| Volatility | 14.49 | ||
| 14-Day RSI | 73.7 | ||
| 14-Day ATR ($) | 3.989914 | ||
| 20-Day SMA ($) | 172.7445 |
Fundamental Data
| Name | Value | ||
|---|---|---|---|
| Market Cap (Mil $) | 8,805.92 | ||
| Shares Outstanding (Mil) | 47 | ||
| PE Ratio | 22.58 | ||
| PE Ratio (10y Range) | - | ||
| PE Ratio (10y Median) | - | ||
| PB Ratio | 4.78 | ||
| PB Ratio (10y Range) | - | ||
| PB Ratio (10y Median) | - |
Dividend Data
| Name | Value | ||
|---|---|---|---|
| Dividends per Share (TTM) ($) | - | ||
| Dividend Yield % | 0.22 | ||
| Dividend Yield % (10y Range) | - | ||
| Dividend Yield % (10y Median) | - | ||
| Next Dividend Payment Date | |||
| Dividend Frequency | Quarterly |
IBB iShares Biotechnology ETF Fundamental Charts
Historical TTM Price-to-Earnings for IBB iShares Biotechnology ETF
Historical TTM Price-to-Earnings without NRI for IBB iShares Biotechnology ETF
Historical Price-to-Book Ratio for IBB iShares Biotechnology ETF
Historical Dividend Yields for IBB iShares Biotechnology ETF
iShares Biotechnology ETF Technical Indicators
Moving Average
Momentum
Gurus Latest Trades with NAS:IBB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:IBB is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
iShares Biotechnology ETF Top Holdings of 2026-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GILD | Gilead Sciences Inc | 4,515,707 | 629,354.1 | -17.66% | 7.760 | -1.43% | 0.360 | -5.96% | +5.47% | 158,772.0 | Drug Manufacturers | |
AMGN | Amgen Inc | 1,733,148 | 609,808.1 | -13.24% | 7.520 | -1.04% | 0.320 | +2.23% | +11.07% | 193,393.7 | Drug Manufacturers | |
VRTX | Vertex Pharmaceuticals Inc | 1,354,033 | 604,629.9 | -14.93% | 7.450 | -1.29% | 0.530 | +8.29% | +8.38% | 124,704.8 | Biotechnology | |
REGN | Regeneron Pharmaceuticals Inc | 758,232 | 585,840.4 | +1.65% | 7.220 | +0.12% | 0.720 | -16.24% | -17.78% | 66,352.6 | Biotechnology | |
ALNY | Alnylam Pharmaceuticals Inc | 979,642 | 324,134.2 | +2.42% | 4.000 | +0.09% | 0.730 | -11.21% | -26.73% | 38,901.6 | Biotechnology | |
INSM | Insmed Inc | 1,587,887 | 259,651.3 | +2.43% | 3.200 | +0.08% | 0.730 | -29.96% | -40.60% | 22,407.9 | Biotechnology | |
ARGX | argenx SE | 341,883 | 249,660.1 | +14.59% | 3.080 | +0.39% | 0.550 | +27.85% | +5.33% | 55,420.0 | Biotechnology | |
BIIB | Biogen Inc | 1,091,046 | 200,021.5 | +1.07% | 2.470 | +0.03% | 0.740 | +13.07% | +22.75% | 31,894.0 | Drug Manufacturers | |
NTRA | Natera Inc | 980,622 | 196,114.6 | +1.29% | 2.420 | +0.03% | 0.680 | +33.53% | +14.33% | 37,509.5 | Medical Diagnostics & Research | |
UTHR | United Therapeutics Corp | 315,509 | 187,090.5 | +3.05% | 2.310 | +0.07% | 0.740 | +1.83% | +11.29% | 23,018.0 | Drug Manufacturers |
iShares Biotechnology ETF's Historical Top Holdings Breakdowns
iShares Biotechnology ETF's Top Stock Picks
View Full List
| Ticker |
|---|
GILD |
VRTX |
AMGN |
| RNAM Unlock Delisted |
| ASND Unlock Delisted |
ARGX |
| DVAX Unlock Delisted |
ROIV |
REGN |
MIRM |
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
GILD | Gilead Sciences Inc | 2026-03-31 | Reduce Reduce | -1.43% | 118.3 ($140.04) 155.8 | $127.88 | -8.68% | Reduce -17.66% | 4,515,707 | -968,529 | |
VRTX | Vertex Pharmaceuticals Inc | 2026-03-31 | Reduce Reduce | -1.29% | 433.07 ($466.29) 499.17 | $491.34 | 5.37% | Reduce -14.93% | 1,354,033 | -237,573 | |
AMGN | Amgen Inc | 2026-03-31 | Reduce Reduce | -1.04% | 320.72 ($356.5) 388.16 | $358.33 | 0.51% | Reduce -13.24% | 1,733,148 | -264,583 | |
| RNAM Unlock Delisted | Avidity Biosciences Inc | 2026-03-31 | Sold Out Sold Out | -0.88% | 70.63 ($71.2) 71.47 | $71.34 | 0.20% | Sold Out | 0 | -1,018,024 | |
| ASND Unlock Delisted | Ascendis Pharma AS | 2026-03-31 | Sold Out Sold Out | -0.87% | 202.99 ($224.17) 242.09 | $244.26 | 8.96% | Sold Out | 0 | -341,419 | |
ARGX | argenx SE | 2026-03-31 | Add Add | +0.39% | 663.93 ($782.53) 864.42 | $885.80 | 13.20% | Add 14.59% | 341,883 | 43,533 | |
| DVAX Unlock Delisted | Dynavax Technologies Corp | 2026-03-31 | Sold Out Sold Out | -0.16% | 15.38 ($15.52) 15.72 | $15.50 | -0.13% | Sold Out | 0 | -861,108 | |
ROIV | Roivant Sciences Ltd | 2026-03-31 | Add Add | +0.15% | 21.14 ($25.69) 29.72 | $34.07 | 32.62% | Add 14.22% | 3,642,557 | 453,349 | |
REGN | Regeneron Pharmaceuticals Inc | 2026-03-31 | Add Add | +0.12% | 732.87 ($765.59) 812.27 | $632.90 | -17.33% | Add 1.65% | 758,232 | 12,321 | |
MIRM | Mirum Pharmaceuticals Inc | 2026-03-31 | Add Add | +0.10% | 75.56 ($94.07) 108.62 | $123.72 | 31.52% | Add 27.03% | 392,677 | 83,559 |
iShares Biotechnology ETF Total Holding History ($B)
iShares Biotechnology ETF's Asset Allocation
iShares Biotechnology ETF Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
iShares Biotechnology ETF's Hypothetical Growth since 2026-03-31
iShares Biotechnology ETF's Yearly Returns
This information is only displayed for Gurus who publicly disclose audited performance records; most hedge funds and private investment firms do not publish such data or only provide limited historical performance information.
| Year | Portfolio % | % | Excess Gain % |
|---|
iShares Biotechnology ETF's Holdings Heat Map
Size field: